The most common mutation types activating the AKT pathway in other cancer types are inactivation of PTEN tumor suppressor gene, which is not mutated in human retinoblastoma, or gain-of-function point mutations in PI3K. This evidence concerns the gene PIK3CA and retinoblastoma.